Guyasuta Investment Advisors Inc Amgen Inc Transaction History

Guyasuta Investment Advisors Inc

$1.51 Billion
Q3 2024

A detailed history of Guyasuta Investment Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 3,749 shares of AMGN stock, worth $984,674. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,749

Previous 3,082 21.64%

Holding current value

$984,674

Previous $962,000 25.47%

% of portfolio

0.08%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $206,356 - $225,032	667 Added 21.64%	3,749 $1.21 Million
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $227,573 - $256,729	-890 Reduced 22.41%	3,082 $887,000
Q2 2023 Jul 17, 2023	BUY	$214.27 - $253.37 $33,426 - $39,525	156 Added 4.09%	3,972 $881,000
Q4 2022 Jan 30, 2023	BUY	$229.03 - $291.01 $127,569 - $162,092	557 Added 17.09%	3,816 $1 Million
Q3 2022 Oct 25, 2022	SELL	$224.46 - $253.15 $4,489 - $5,063	-20 Reduced 0.61%	3,259 $735,000
Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $23,993 - $26,700	104 Added 3.28%	3,279 $798,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $11,674 - $13,678	-55 Reduced 1.7%	3,175 $675,000
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $11,679 - $12,957	50 Added 1.57%	3,230 $787,000
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $72,487 - $86,319	335 Added 11.78%	3,180 $731,000
Q3 2020 Oct 28, 2020	BUY	$234.65 - $260.95 $70,395 - $78,285	300 Added 11.79%	2,845 $723,000
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $10,681 - $13,107	54 Added 2.17%	2,545 $600,000
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $24,784 - $32,871	136 Added 5.77%	2,491 $505,000
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $61,809 - $74,060	355 Added 17.75%	2,355 $455,000
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $57,511 - $67,416	345 Added 20.85%	2,000 $369,000
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $89,200 - $104,125	500 Added 43.29%	1,655 $322,000
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $14,944 - $16,785	-90 Reduced 7.23%	1,155 $213,000
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $15,248 - $17,820	90 Added 7.79%	1,245 $212,000
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $193,219 - $220,605	1,155	1,155 $215,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.

Account

Guyasuta Investment Advisors Inc Amgen Inc Transaction History